Across TCGA pan-cancer cohorts, LINC01692 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of LINC01692’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where LINC01692 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC01692 is over-expressed in tumor, although a few such as COAD show the opposite, repressed pattern.

COAD and LIHC are the cancer types where LINC01692 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01692 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Female	All	−0.005	.038	2	view →
LIHC	All	All	+0.003	.049	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: LINC01692 RNA expression & survival · all LINC01692 data types